A carregar...

Supportive care treatments for toxicities of anti-egfr and other targeted agents

Targeting of the epidermal growth factor receptor (egfr) pathway has become routine practice in the treatment of lung carcinoma. As more health authorities approve targeted compounds in a variety of treatment lines, use of this approach is expected only to increase. Gefitinib, an oral tyrosine kinas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Melosky, B.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3377756/
https://ncbi.nlm.nih.gov/pubmed/22787412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.1054
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!